Comparing Alphagan P vs Brimonidine Ophthalmic
| Alphagan P (brimonidine) | Brimonidine ophthalmic |
|
|---|
| Alphagan P (brimonidine) | Brimonidine ophthalmic |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Alphagan P may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension, Eye Redness. Brimonidine ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Intraocular Hypertension
|
|||||||||||||||
| More about Alphagan P (brimonidine) | More about Brimonidine ophthalmic | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Alphagan P has an average rating of 5.0 out of 10 from a total of 8 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 50% reported a negative effect. |
Brimonidine ophthalmic has an average rating of 3.4 out of 10 from a total of 192 ratings on Drugs.com. 21% of reviewers reported a positive effect, while 71% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Alphagan P side effects |
View all Brimonidine ophthalmic side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Alphagan P prices |
View all Brimonidine ophthalmic prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other brimonidine brands include: Lumify, Lumify Preservative Free, Qoliana | Alphagan P, Lumify, Lumify Preservative Free, Qoliana | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 367 drugs are known to interact with Alphagan P:
|
A total of 367 drugs are known to interact with Brimonidine ophthalmic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 16, 2001 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.